We are very excited by this research and we believe that this therapeutic T cell vaccination approach holds great promise for patients suffering from rheumatoid arthritis.

We are extremely pleased by these results. We believe that they are the first validation of the therapeutic vaccination approach in infectious diseases. These data constitute a significant breakthrough and validate our vaccine technology platform. Our objective is an effective vaccine for pre-cancerous lesions to speed up the fight against cervical cancer which remains a serious health concern globally.

Stem cell research holds out the promise of finding cures and treatments for a wide range of diseases.

Stem cell research holds enormous promise for easing human suffering, and federal support is critical to its success.

I wholeheartedly support umbilical stem cell research, but also support embryonic stem cell research.

This research proves that the promise of massive operational savings is unrealistic when you take into account the costs of procurement and ongoing contract management.